Comparing first-line antiretroviral therapies for HIV

[From Clinical Advisor, Sep 30, 2016] Among patients who are HIV-positive, dolutegravir and low-dose efavirenz are more tolerable and effective than standard-dose efavirenz, while dolutegravir offers slight improvement regarding viral suppression efficacy and tolerability, according to a meta-analysis published in the Lancet HIV.

For more, click here.